已核实 DOI PubMed 相关产品: 12

Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation

Journal 2020 · IF 15.84 · 7(17): 2000411 · 发表于 2020 年 7 月 29 日
作者: Qinjun Chen,Yongqing He,Yu Wang,Chao Li,Yujie Zhang,Qin Guo,Yiwen Zhang,Yongchao Chu,Peixin Liu,Hongyi Chen,Zheng Zhou,Wenxi Zhou,Zhenhao Zhao,Xiaomin Li,Tao Sun,Chen Jiang
阅读全文 在 PubMed 查看

摘要

Lack of tumor-infiltration lymphocytes (TILs) and resistances by overexpressed immunosuppressive cells (principally, myeloid-derived suppressor cells (MDSCs)) in tumor milieu are two major challenges hindering the effectiveness of immunotherapy for “immune-cold” tumors. In addition, the natural physical barrier existing in solid cancer also limits deeper delivery of drugs. Here, a tumor-targeting and light-responsive-penetrable nanoplatform (Apt/PDGs ^ s@pMOF) is developed to elicit intratumoral infiltration of cytotoxic T cells (CTLs) and reeducate immunosuppressive microenvironment simultaneously. In particular, porphyrinic metal–organic framework (pMOF)–based photodynamic therapy (PDT) induces tumor immunogenic cell death (ICD) to promote CTLs intratumoral infiltration and hot “immune-cold” tumor. Upon being triggered by PDT, the nearly 10 nm adsorbed drug-loaded dendrimer de-shields from the nanoplatform and spreads into the deeper tumor, eliminating MDSCs and reversing immunosuppression, eventually reinforcing immune response. Meanwhile, the designed nanoplatform also has a systemic MDSC inhibition effect and moderate improvement of overall antitumor immune responses, resulting in effective suppression of distal tumors within less significant immune-related adverse effects (irAEs) induced.

本研究中使用的阿拉丁产品

12 款产品在本文中被引用